eak-3

Caenorhabditis elegans

Expressed in XXXL and XXXR.

eak-4

Caenorhabditis elegans

Involved in dauer larval development. Located in plasma membrane. Expressed in XXXL and XXXR.

eak-6

Caenorhabditis elegans

Predicted to enable histone H2AXY142 phosphatase activity and protein tyrosine phosphatase activity. Involved in dauer larval development. Located in plasma membrane. Expressed in XXXL and XXXR.

eak-7

Caenorhabditis elegans

Predicted to be involved in response to oxidative stress. Located in plasma membrane. Expressed in body wall musculature; hypodermis; pharynx; and vulva. Is an ortholog of human MEAK7 (MTOR associated protein, eak-7 homolog).

sdf-9

Caenorhabditis elegans

Predicted to enable protein tyrosine phosphatase activity. Involved in dauer larval development. Located in plasma membrane. Expressed in XXXL; XXXR; and head. Human ortholog(s) of this gene implicated in artery disease (multiple); proliferative diabetic retinopathy; and type 2 diabetes mellitus. Is an ortholog of human PTPN1 (protein tyrosine phosphatase non-receptor type 1).

B0379.10

Caenorhabditis elegans

Is affected by cep-1; dlc-1; and ogt-1 based on RNA-seq studies.

C06G1.15

Caenorhabditis elegans

Is affected by adr-1; etr-1; and ogt-1 based on RNA-seq studies.

F18C5.15

Caenorhabditis elegans

Is affected by cep-1; dlc-1; and ogt-1 based on RNA-seq studies.

F38A3.3

Caenorhabditis elegans

Is affected by cep-1; nfki-1; and ogt-1 based on RNA-seq studies.

K03C7.9

Caenorhabditis elegans

Is affected by cep-1; etr-1; and glp-1 based on RNA-seq studies.